Patient Perceptions Regarding Anatomic Versus Reverse Total Shoulder Arthroplasty

Overview

About this study

The aim of this study is to evaluate patient beliefs about the efficacy and outcomes of anatomic versus reverse total shoulder arthroplasty.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patients over age 18 presenting to the shoulder and elbow clinic as a new consult for evaluation of shoulder pain between September 2024 and April 2025, primary glenohumeral arthritis, have previously heard of anatomic and reverse total shoulder arthroplasty.

Exclusion Criteria: 

  • Under age 18, have not heard of anatomic and reverse total shoulder arthroplasty, have undergone prior ipsilateral shoulder arthroplasty, patients with massive rotator cuff tears without arthritis, patients with septic arthritis, patients with acute proximal humerus fractures or proximal humerus nonunions, non-English speaking/reading patients.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 9/3/2024. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Jonathan Barlow, M.D.

Open for enrollment

Contact information:

Orthopedic Research Clinical Unit

(507) 266-6402

ORCU@mayo.edu

More information

Publications

Publications are currently not available